ROLE OF RISK FACTOR MANAGEMENT IN PROGRESSION AND REGRESSION OF CORONARY AND FEMORAL-ARTERY ATHEROSCLEROSIS

被引：21

作者：

GLUECK, CJ

机构：

[1] UNIV CINCINNATI,COLL MED,LIPID RES CTR,CINCINNATI,OH 45267

[2] UNIV CINCINNATI,COLL MED,CTR CLIN INFORMAT,CINCINNATI,OH 45267

来源：

关键词：

D O I：

10.1016/0002-9149(86)90664-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：G35 / G41

页数：7

共 34 条

[1] [Anonymous], 1984, JAMA, V251, P365
[2] DIET, LIPOPROTEINS, AND THE PROGRESSION OF CORONARY ATHEROSCLEROSIS - THE LEIDEN INTERVENTION TRIAL
ARNTZENIUS, AC
KROMHOUT, D
BARTH, JD
REIBER, JHC
BRUSCHKE, AVG
BUIS, B
VANGENT, CM
KEMPENVOOGD, N
STRIKWERDA, S
VANDERVELDE, EA
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (13) : 805 - 811
[3] REGRESSION AND PROGRESSION OF EARLY FEMORAL ATHEROSCLEROSIS IN TREATED HYPERLIPOPROTEINEMIC PATIENTS
BARNDT, R
BLANKENHORN, DH
CRAWFORD, DW
BROOKS, SH
[J]. ANNALS OF INTERNAL MEDICINE, 1977, 86 (02) : 139 - 146
[4] BLANKENHORN DH, 1981, ARTERIOSCLEROSIS, V1, P242
[5] ANGIOGRAPHY FOR STUDY OF LIPID-LOWERING THERAPY
BLANKENHORN, DH
SANMARCO, ME
[J]. CIRCULATION, 1979, 59 (02) : 212 - 214
[6] BLANKENHORN DH, 1978, CIRCULATION, V57, P355, DOI 10.1161/01.CIR.57.2.355
[7] BLANKENHORN DH, 1982, CARDIOVASC REV REP, V3, P1063
[8] EFFECTS OF THERAPY WITH CHOLESTYRAMINE ON PROGRESSION OF CORONARY ARTERIOSCLEROSIS - RESULTS OF THE NHLBI TYPE-II CORONARY INTERVENTION STUDY
BRENSIKE, JF
LEVY, RI
KELSEY, SF
PASSAMANI, ER
RICHARDSON, JM
LOH, IK
STONE, NJ
ALDRICH, RF
BATTAGLINI, JW
MORIARTY, DJ
FISHER, MR
FRIEDMAN, L
FRIEDEWALD, W
DETRE, KM
EPSTEIN, SE
[J]. CIRCULATION, 1984, 69 (02) : 313 - 324
[9] CLINICAL ANGIOGRAPHIC REGRESSION OF ATHEROSCLEROSIS AFTER PARTIAL ILEAL BYPASS
BUCHWALD, H
MOORE, RB
RUCKER, RD
AMPLATZ, K
CASTANEDA, WR
FRANCOZ, RA
PASTERNAK, RC
VARCO, RL
[J]. ATHEROSCLEROSIS, 1983, 46 (01) : 117 - 128
[10] BUCHWALD H, 1982, LIPOPROTEINS CORONAR, P417